Gustav Christensen
Chairman at MORPHIC HOLDING, INC.
Net worth: 3 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Praveen Tipirneni | M | 55 |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 9 years |
| Timothy Springer | M | 76 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 10 years |
| Robert Farrell | M | 58 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 9 years |
| Marc Schegerin | M | 48 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 4 years |
| William DeVaul | M | 53 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 years |
| Stephen DiPalma | M | 66 |
Phytera, Inc.
 Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | 26 years |
| Bruce Rogers | M | 55 | 8 years | |
| Nilesh Kumar | M | 47 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 years |
| Cameron McDonough | M | 53 | 7 years | |
| Vikas Goyal | M | 45 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 years |
| Jason Rhodes | M | 54 | 8 years | |
| Joseph Slattery | M | 59 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 years |
| Otello Stampacchia | M | 55 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 6 years |
| Martin Edwards | M | 68 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 4 years |
| Susannah Gray | F | 63 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 3 years |
| Norbert W. Bischofberger | M | 68 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 5 years |
| Amir Nashat | M | 51 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 7 years |
| Maren Killackey | F | - | - | |
| Blaise Lippa | M | - | 9 years | |
| Catherine Stehman-Breen | M | 61 | 7 years | |
| Ronald Cooper | M | 61 | 3 years | |
| Nisha Nanda | M | 49 | 3 years | |
| Donald Nicholson | M | 67 | 7 years | |
| Charles Rowland | M | 65 | 6 years | |
| Jeff Jonas | M | 71 | 6 years | |
| Brihad Abhyankar | M | - |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | 2 years |
| Matthew Norkunas | M | 46 | 4 years | |
| Antoinette Paone | F | 46 | 6 years | |
| Anthony Quinn | M | 62 | 7 years | |
| Yalonda Howze | F | 52 | 1 years | |
| Ulrich Von Adrian | M | - |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Dannielle Appelhans | F | 41 | 2 years | |
| Phillip Samayoa | M | 37 | 6 years | |
| Matthew Stanton | M | 51 | 7 years | |
| Aaron Pelta | M | - | 5 years | |
| Mark Murcko | M | 64 |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | - |
| Malcolm Morville | M | 78 |
Phytera, Inc.
Phytera, Inc. Miscellaneous Commercial ServicesCommercial Services Phytera, Inc. develops plant-based and marine-based pharmaceuticals. The company is headquartered in Shrewsbury, MA. | - |
| Joanne Gibbons | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Ashe | M | 57 | 13 years | |
| George Migausky | M | 69 | 8 years | |
| Henry E. Blair | M | 80 | 27 years | |
| David J. McLachlan | M | 86 | 17 years | |
| Ivana Magovcevic-Liebisch | M | 55 | 12 years | |
| Lester Knight | M | 65 | 15 years | |
| Carolyn Beaty Scimemi | F | - | - | |
| Susan B. Bayh | F | 64 | 9 years | |
| Jennifer Robinson | F | - | 5 years | |
| Thomas Lenox Kempner | M | 96 | 21 years | |
| Paolo Pucci | M | 63 | 5 years | |
| William Earnest Pullman | M | 70 | - | |
| Marc Kozin | M | 62 | 4 years | |
| Mark Angelino | M | 51 | 5 years | |
| Douglas Kerr | M | 57 | 5 years | |
| Ronald Cohen | M | 68 | 5 years | |
| Mary Gray | M | 71 | 12 years | |
| Sara Den Besten | F | - | - | |
| Stephen S. Galliker | M | 77 | 9 years | |
| James Fordyce | M | 81 | 21 years | |
| Henry Lewis | M | 98 | 17 years | |
| Cristina Csimma | M | 65 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 12 years |
| Joan Nickerson | F | 56 | 4 years | |
| Satinder K. Sethi | M | - | - | |
| Joseph P. Dougherty | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Ramy Farid | M | 59 | 3 years | |
| Todd Bazemore | M | 53 | 2 years | |
| Nancy A. Krejsa | F | 66 | 14 years | |
| Robert J. Steininger | M | 69 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 16 years |
| Patrick Taylor Horn | M | 69 | 3 years | |
| Abbie Celniker | M | 65 | 1 years | |
| Thomas Graney | M | 60 | - | |
| Marc Blaustein | M | 61 | 5 years | |
| Shelby Walker | F | - | 6 years | |
| Yung H. Chyung | M | 48 | 5 years | |
| Peter G. Linde | M | 57 | 1 years | |
| Tracy Zimmermann | M | 54 | 4 years | |
| John A. Bardis | M | 67 | 9 years | |
| David L. Berstein | M | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Marc Goldberg | M | 67 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Timothy J. Wollaeger | M | 80 | 8 years | |
| Garen Bohlin | M | 76 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 14 years |
| Clive R. Wood | M | 63 | 6 years | |
| Charles J. Hansen | M | 76 | 5 years | |
| Randel Woodgrift | M | 62 | 14 years | |
| John F. Gaither | M | 74 | 18 years | |
| Ramon M. Perez | M | 70 | 16 years | |
| William E. Saxelby | M | 67 | 21 years | |
| Michael Mussallem | M | 71 | 21 years | |
| R. Greer | M | 65 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 6 years |
| Burt Adelman | M | 71 | 4 years | |
| Phillip Charles Henderson | M | 83 | 7 years | |
| Constantine E. Anagnostopoulos | M | 101 | 20 years | |
| Stephen D. Chubb | M | 80 | 2 years | |
| Barbara Dalton | M | 69 | - | |
| Donald Middlebrook | M | 73 | 15 years | |
| Tuan Ha-Ngoc | M | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | - |
| David K. Stone | M | 67 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | - |
| Robert H. Tidwell | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Clifford A. Hewitt | M | - | 1 years | |
| A. Peter Lawson | M | 77 | 2 years | |
| Kevin Swan | M | - | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gustav Christensen
- Personal Network
